Evaluation of Transcranial Magnetic Stimulation for Detecting Subclinical Neuroplastic Changes in Newly Diagnosed Leprosy Patients without Peripheral Neuritis

Anshika Singh; Suresh Mani; Arvind Krishna

doi:10.15391/prrht.2026-11(1).06

Authors

Anshika Singh Department of Physiotherapy, Lovely Professional University, Jalandhar, Punjab, India https://orcid.org/0000-0002-2254-6632
Suresh Mani Department of Physiotherapy, Lovely Professional University, Jalandhar, Punjab, India https://orcid.org/0000-0003-1703-092X
Arvind Krishna Department of Dermatology, Swami Vivekanand Subharti University, Meerut, Uttar Pradesh, India https://orcid.org/0000-0003-0506-3708

DOI:

https://doi.org/10.15391/prrht.2026-11(1).06

Keywords:

Transcranial magnetic stimulation, leprosy, neuroplasticity, peripheral neuritis

Abstract

Purpose. Leprosy is a chronic infectious disease predominantly affecting peripheral nerves, often leading to sensory and motor deficits. Early detection of neuroplastic changes before clinical manifestations may improve diagnosis and rehabilitation. Transcranial magnetic stimulation (TMS) is a non-invasive tool capable of assessing corticospinal excitability and detecting subclinical central nervous system involvement.

Material & Methods. A cross-sectional study was conducted involving 51 newly diagnosed leprosy patients aged 18–45 years without clinical signs of peripheral neuritis and 51 age- and sex-matched non-leprosy (healthy) controls. Resting motor thresholds and motor evoked potential (MEP) amplitudes were measured bilaterally in four hand muscles: the first dorsal interosseous, abductor pollicis brevis, extensor pollicis brevis, and abductor digiti minimi, using TMS and electromyography.

Results. Leprosy patients exhibited significantly elevated motor thresholds across all examined muscles compared with controls (e.g., right first dorsal interosseous mean threshold 65.2 vs. 55.1, p<0.0001). Concurrently, MEP amplitudes were markedly reduced in the leprosy group (e.g., right abductor pollicis brevis 36.75 vs. 74.35, p<0.0001), indicating decreased corticospinal excitability and early neuroplastic changes despite absence of clinical peripheral neuritis.

Conclusions. TMS may detect early subclinical corticospinal pathway dysfunction in newly diagnosed leprosy patients without peripheral neuritis, highlighting its potential as a sensitive diagnostic and monitoring tool for neuroplastic alterations in leprosy.

References

Walker SL, Lockwood DNJ. Leprosy. Clin Dermatol. 2007;25(2):165-72. https://doi.org/10.1016/j.clindermatol.2006.05.012

World Health Organization. Global leprosy update 2023. Geneva: World Health Organization; 2023. Available from: www.who.int

Central Leprosy Division, Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India. NLEP-annual report 2015-16. New Delhi: National Leprosy Eradication Programme; 2016.

Kumar B. World leprosy day 2015: renewing commitment for a leprosy free world! Indian J Med Res. 2015;141 Suppl 1:1-4. https://doi.org/10.4103/0971-5916.154476

Li C, Liu SY, Pi W, Zhang PX. Cortical plasticity and nerve regeneration after peripheral nerve injury. Neural Regen Res. 2021;16(8):1518-23. https://doi.org/10.4103/1673-5374.303008

Goodhue WJ. [The diagnosis of leprosy]. 1906.

Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966;34(3):255-73.

Smith WCS, Saunderson P. Leprosy. Clin Evid. 2010;2010:0915. https://doi.org/10.1063/pt.4.1831

Britton WJ, Lockwood DNJ. Leprosy. Lancet. 2004;363(9416):1209-19. https://doi.org/10.1016/S0140-6736(04)15952-7

World Health Organization. International classification of functioning, disability and health: ICF. Geneva: World Health Organization; 2001. Available from: www.who.int

Trojan S, Krulichová V, Langmajerová I. Plasticity of the brain in neuroontogenesis. Prague Med Rep. 2004;105(2):97-110.

Liew SL, Santarnecchi E, Ho JC, Chevrier J. Non-invasive brain stimulation in neurorehabilitation: local and distant effects for motor recovery. Front Hum Neurosci. 2014;8:378. https://doi.org/10.3389/fnhum.2014.00378

Bergado-Rosado JA, Almaguer-Melián W. Mecanismos celulares de la neuroplasticidad. Rev Neurol. 2000;31(11):1074-95. https://doi.org/10.33588/rn.3111.2000340

Johnston MV. Plasticity in the developing brain: implications for rehabilitation. Dev Disabil Res Rev. 2009;15(2):94-101. https://doi.org/10.1002/ddrr.46

Rossini PM, Burke D, Chen R, Cohen LG, Daskalakis Z, Di Iorio R, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee. Clin Neurophysiol. 2015;126(6):1071-107. https://doi.org/10.1016/j.clinph.2015.02.001

Groppa S, Oliviero A, Eisen A, Quartarone A, Cohen LG, Mall V, et al. A practical guide to diagnostic transcranial magnetic stimulation. Clin Neurophysiol. 2012;123(11):2149-55. https://doi.org/10.1016/j.clinph.2012.01.020

Chao Z, Liu G, Zhang F, Zhang J. Transcranial magnetic stimulation to treat neuropathic pain: a narrative review. Brain Stimul. 2024;17(2):245-56. https://doi.org/10.1016/j.brs.2024.01.012

Wang X, Li Y, Wang Q, Zhang Y. Effects of repetitive transcranial magnetic stimulation on neuropathic pain: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2022;134:104531. https://doi.org/10.1016/j.neubiorev.2021.12.024

de Oliveira MBB, Diniz LM. Leprosy among children under 15 years of age: literature review. An Bras Dermatol. 2016;91(4):665-70. https://doi.org/10.1590/abd1806-4841.20163661

Vucic S, Chen KHS, Kiernan MC, Hallett M, Benninger DH, Di Lazzaro V, et al. Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders: updated report of an IFCN committee. Clin Neurophysiol. 2023;150:131-75. https://doi.org/10.1016/j.clinph.2023.03.010

Bunse T, Wobrock T, Strube W, Padberg F, Palm U, Falkai P, et al. Motor cortical excitability assessed by transcranial magnetic stimulation in psychiatric disorders: a systematic review. Brain Stimul. 2014;7(2):158-69. https://doi.org/10.1016/j.brs.2013.10.001

Uncini A, Kuwabara S. Nodopathies of the peripheral nerve: an emerging concept. J Neurol Neurosurg Psychiatry. 2015;86(11):1186-95. https://doi.org/10.1136/jnnp-2014-310097

Menon P, Kiernan MC, Vucic S. Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS. Clin Neurophysiol. 2015;126(4):803-9. https://doi.org/10.1016/j.clinph.2014.09.024

Calderone A, Aloisi MC, Casella C, Fiannacca S, Cosenza B, Quartarone A, Calabrò RS. The neurological impact of leprosy: manifestations and treatment approaches. Neurology International. 2024;16(6):1492-508. https://doi.org/10.3390/neurolint16060111

Rashidi M, Pitton Rissardo J, Byroju VV, Fornari Caprara AL, Rashidi F, Prathiraja O, Moharam H, Elendu CC, Bahar M, Jayasinghe M. Exploring the Neurological Manifestations of Leprosy: Clinical Insights and Implications. Cureus. 2025 Jan 21;17(1):e77799. https://doi.org/10.7759/cureus.77799

Turrini, S., Fiori, F., Chiappini, E. et al. Gradual enhancement of corticomotor excitability during cortico-cortical paired associative stimulation. Sci Rep 12, 14670 (2022). https://doi.org/10.1038/s41598-022-18774-9